Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS)

Clinical trial NCT05089084 · COMPLETED

Trial details

NCT number: NCT05089084
Sponsor: Arrowhead Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Familial Chylomicronemia

Start date: 2021-12-14
Primary completion: 2024-04-29
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.